Case Study: Empowering Precision Medicine through Multiplexed PCR-based Diagnostics

This case study outlines our collaboration with a diagnostics instrumentation company on a mission to redefine patient care through precision medicine. The endeavor was fueled by the creation of a multiplexed PCR-based diagnostic system, a powerful tool designed to identify specific mutations in genes linked to drug response. Here, we dive into the pragmatic approach that merged data science with molecular diagnostics, unveiling how this synergy transformed patient treatment by tailoring therapies to individual genetic profiles. This study underscores our commitment to forging impactful solutions at the intersection of technology, genetics, and personalized healthcare.

Client Background

Our client, a pioneering diagnostics instrumentation company, embarked on a journey to harness precision medicine by developing a state-of-the-art assay. The mission was to create a multiplexed PCR-based diagnostic system capable of amplifying and identifying specific mutations in genes linked to drug response. This innovative approach aimed to revolutionize patient treatment by tailoring therapies to individual genetic profiles.


Creating a robust assay that could accurately and efficiently identify specific mutations within targeted gene regions presented a multifaceted challenge. The diagnostic system needed to combine multiplex PCR amplification, allele-specific hybridization, and advanced targeted sequencing technologies while incorporating variant calling algorithms for accurate mutation detection.


Our strategic approach embraced cutting-edge computational techniques to construct an effective diagnostic system:

1. Multiplex PCR Amplification

Our approach to designing and optimizing the multiplex PCR assay involved a series of data-driven steps.

   a. Target Selection and Primer Design

Collaborating closely with the client’s domain experts, we helped identify the genes and specific regions of interest associated with drug response. Using existing genetic databases and bioinformatics tools, we computationally designed primers the client could use to amplify these targeted regions.

   b. Experimental Design and Sample Preparation

We devised an experimental plan that balanced the need for multiplex amplification with minimizing potential primer interactions. To ensure accurate results, we advised the client on appropriate sample preparation and quality control protocols.

   c. PCR Optimization and Validation

Employing computational simulations and empirical testing, we optimized the multiplex PCR conditions to ensure efficient and specific amplification of the targeted gene regions. Through iterative cycles of testing and adjustment, we validated the assay’s performance.

2. Allele-Specific Hybridization or Targeted Sequencing

Our data science expertise played a pivotal role in executing allele-specific hybridization or targeted sequencing methodologies.

   a. Probe Design or Targeted Sequencing Panels

For allele-specific hybridization, we designed custom probes specific to the mutated regions identified in the genes of interest. Alternatively, for targeted sequencing, we curated panels of primers for the sequenced regions.

   b. Data Acquisition and Preprocessing

Whether through hybridization or sequencing, we ensured high-quality data acquisition. We cleaned and filtered the acquired data to remove noise and artifacts, ensuring that downstream analysis would be accurate.

3. Variant Calling Algorithms

Employing sophisticated variant calling algorithms, we analyzed the sequencing data to discern mutations and genetic variations.

   a. Data Alignment and Mapping

We aligned the sequenced reads to the reference genome using advanced alignment algorithms. This step ensured that the reads were accurately mapped to the corresponding genomic regions.

   b. Variant Calling and Filtering

Employing variant calling algorithms, we identified genetic variations and mutations within the targeted regions. We applied stringent filters to distinguish true mutations from sequencing errors or artifacts.

   c. Annotation and Interpretation

Our team annotated the identified variants using genetic databases and resources. This involved determining whether the mutations were known to impact drug response or clinical outcomes, providing crucial context for interpretation.


The culmination of our efforts resulted in a preliminary multiplexed PCR-based diagnostic system that could identify specific mutations within genes linked to drug response.


The developed diagnostic assay has the potential to help pave the way for precision medicine, enabling clinicians to tailor treatment plans based on individual genetic profiles. By identifying mutations associated with drug response, the assay offered a promising personalized approach to patient care, optimizing therapeutic outcomes.


This case study underscores our role in fostering groundbreaking advancements in diagnostics instrumentation. Through the integration of multiplex PCR, allele-specific hybridization, and targeted sequencing, we help the client create a first model of a robust diagnostic system capable of pinpointing mutations with high accuracy. The study exemplifies our commitment to precision medicine, illuminating how cutting-edge technology and innovative strategies converge to redefine patient care.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top